Home » 論文ナビSCOPE » キーワード分析 » 【論文データ】lung cancer（肺癌）の国内研究動向まとめ 【論文データ】lung cancer（肺癌）の国内研究動向まとめ 論文ナビは研究者によって運営される論文解説プラットフォームです。このページでは、最近二年間(2016-2017)で発表された文献データを独自に収集・集計して分かりやすくまとめました。論文キーワードマップ、代表的な研究機関、頻出キーワード、分野のシェア、分野関連図、関連文献等により、今までない情報を提供します。 統計データ lung cancernon-small-cell lung cancer (NSCLC)small cell lung cancer (SCLC)surgeryepidermal growth factor receptor (EGFR)prognosisbevacizumabEGFR mutationchemotherapynivolumabinterstitial lung diseaseadenocarcinomastereotactic radiotherapyprognostic factorimmunohistochemistryafatiniberlotinibPD-L1lung cancer surgerycomputed tomography (CT)radiotherapyimmunotherapyalectinibamrubicinsegmentectomyS-1positron emission tomography (PET)survivalcisplatinbrain metastasesmutationT790MelderlycarboplatinlobectomyEGFR-TKInext-generation sequencingelderly patientssquamous cell carcinoma (SCC)pemetrexedgefitinibchronic obstructive pulmonary disease (COPD)pulmonary resectionepithelial-mesenchymal transitionbronchoscopydocetaxeloverall survivalmetastasisradiation pneumonitisanaplastic lymphoma kinase (ALK)smokingacute exacerbationCT scanbiomarkerinterstitial pneumoniaepidermal growth factor receptor mutationadjuvant chemotherapynab-paclitaxelcrizotinibapoptosisTNM classificationdrug resistanceemphysemaTGF-betaacquired resistancectDNAresistancecarbon ion radiotherapypostoperative recurrencethoracic surgeryhepatocyte growth factorchemoradiotherapylung cancer stagingplasmachemoresistanceosimertinibphase I studycomplicationthoracoscopic surgeryJapanesesecond line chemotherapyclinical trialpredictive factorlymph node metastasissquamous cell lung cancerNOTCHimmune checkpoint inhibitorLCNECpulmonary functionEML4 ALKtyrosine kinase inhibitortumor-infiltrating lymphocytehistologymagnetic resonance imaging (MRI)PD 1digital PCRperformance statusoutcomeJapandual-energy CTpharmacokineticslung metastasisretrospective studyidiopathic pulmonary fibrosisp53local recurrencelymph nodepulmonary fibrosistoxicitycancer stem cellspolymorphismSUVmaxT790M mutationdiagnosismultiple tumorslymph node dissectioncancer chemotherapyUGT1A1irinotecanramucirumabquality-of-life (QOL)circulating tumor cellsadverse eventsmicroenvironmentvideo-assisted thoracic surgery (VATS)responserecurrencemesotheliomaimmune checkpointoncologycytologymaintenance therapypredictive biomarkerALK rearrangementprecision medicinemeta-analysisprospective studyleptomeningeal carcinomatosispleural effusionvascular endothelial growth factor (VEGF)lung adenocarcinomaparaneoplastic syndromeproton beam therapycachexiamortalityprospectiveprognostic markerEBUS-TBNApostoperativeMETperfusionsingle nucleotide polymorphism (SNP)vascular invasionmigrationMET amplificationidiopathic interstitial pneumoniamicroRNAFDG-PETcell-free DNAsurgical resectionsemaphorin 3Acombined pulmonary fibrosis and emphysemaP-glycoproteinmolecular targeted therapySBRTdisease-free survivaloxidative stresspirfenidoneneutropeniafebrile neutropeniagene polymorphisminduction therapygemcitabinemolecular target drugradiofrequency ablationalbuminhypoxiaER stressaprepitantgastric cancerIL-6tumor-associated macrophagethymidylate synthasepaclitaxelcolon cancerbeta-cateninefficacyradiationtumor progressioncardiovascular surgeryfibroblastatrial fibrillationcomorbidityphotodynamic therapysupportive carecase reportprogression-free survivalimmunogenicitynutritiondose escalationhigh resolution computed tomographyphase II studyHER2deformable image registrationbody mass indexcancer cachexiasarcopeniapneumoniaadverse effectscreeningCD44renal dysfunctiontumor microenvironmentscalable processor architecture (SPARC)immune evasiongeriatric nutritional risk indexbreast cancerBIMcarcinoembryonic antigen (CEA)zoledronic acidPTENtumor markerreproducibilityEZH2wedge resectionPET-CTtherapeutic effecthaptoglobinmethylationearly-stageneutrophil-to-lymphocyte ratiocell proliferationcell deathnephrotoxicityinteractioninflammationphase III studyHB-EGFrisk factoramplificationchemosensitivityEBUS-GSstereotactic radiosurgerygamma knifedisease progressionsalvage surgerypleurodesisJanus kinase (JAK)thrombosiscarcinogenesisKRAS mutationhepatocellular carcinoma (HCC)osteosarcomafollow-upmTOR signalingglycolysischemoradiationinvasionpolymerase chain reaction (PCR)real-time polymerase chain reaction (PCR)ABCB1Monte Carlo simulationmodeling and simulationcost-effectivenessexosomeubiquitin ligaseSkp2p27nationwide surveyshared decision makingalcoholbeerepidermal growth factorplatinum (Pt)etoposidemyasthenia gravismyocarditisinduction chemotherapypancreatic metastasiscancer cellsdistributionthoracoscopypalliative caredyspneaoligomerizationcardiopulmonary bypassheartelectrocardiogram (ECG)contactwhite matter lesionlungdiaphragmbilateralhypoalbuminemiaHIF-1hemodialysischronic kidney disease (CKD)Kampo medicineadenosineKi 67
